These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 28468328)

  • 1. Heparin and Heparin-Derivatives in Post-Subarachnoid Hemorrhage Brain Injury: A Multimodal Therapy for a Multimodal Disease.
    Hayman EG; Patel AP; James RF; Simard JM
    Molecules; 2017 May; 22(5):. PubMed ID: 28468328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of heparin-induced thrombocytopenia Type II in patients with subarachnoid hemorrhage treated with heparin versus enoxaparin.
    Kim GH; Hahn DK; Kellner CP; Komotar RJ; Starke R; Garrett MC; Yao J; Cleveland J; Mayer SA; Connolly ES
    J Neurosurg; 2009 Jan; 110(1):50-7. PubMed ID: 18976056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin Treatment in Aneurysmal Subarachnoid Hemorrhage: A Review of Human Studies.
    Khattar NK; Bak E; White AC; James RF
    Acta Neurochir Suppl; 2020; 127():15-19. PubMed ID: 31407057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin in the treatment of aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Lukito PP; Lie H; Helsa K; July J
    Neurosurg Focus; 2022 Mar; 52(3):E9. PubMed ID: 35231899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin infusions in aneurysmal subarachnoid hemorrhages: clinical considerations for use beyond anticoagulation.
    Kormanyos Z; Reinert JP; Brady P
    Expert Rev Clin Pharmacol; 2022 Dec; 15(12):1415-1421. PubMed ID: 36377793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of heparin on secondary brain injury in patients with subarachnoid hemorrhage: an additional 'H' therapy in vasospasm treatment.
    Bruder M; Won SY; Kashefiolasl S; Wagner M; Brawanski N; Dinc N; Seifert V; Konczalla J
    J Neurointerv Surg; 2017 Jul; 9(7):659-663. PubMed ID: 28153852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of immune inflammation in aneurysmal subarachnoid hemorrhage.
    Zeyu Zhang ; Yuanjian Fang ; Cameron Lenahan ; Sheng Chen
    Exp Neurol; 2021 Feb; 336():113535. PubMed ID: 33249033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Dose Intravenous Heparin Infusion After Aneurysmal Subarachnoid Hemorrhage is Associated With Decreased Risk of Delayed Neurological Deficit and Cerebral Infarction.
    Kole MJ; Wessell AP; Ugiliweneza B; Cannarsa GJ; Fortuny E; Stokum JA; Shea P; Chryssikos T; Khattar NK; Crabill GA; Schreibman DL; Badjatia N; Gandhi D; Aldrich EF; James RF; Simard JM
    Neurosurgery; 2021 Feb; 88(3):523-530. PubMed ID: 33269390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Damage Associated Molecular Pattern Molecules (DAMPs) in Aneurysmal Subarachnoid Hemorrhage (aSAH).
    Chaudhry SR; Hafez A; Rezai Jahromi B; Kinfe TM; Lamprecht A; Niemelä M; Muhammad S
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of Global Cerebral Edema Formation in Aneurysmal Subarachnoid Hemorrhage.
    Hayman EG; Wessell A; Gerzanich V; Sheth KN; Simard JM
    Neurocrit Care; 2017 Apr; 26(2):301-310. PubMed ID: 27995510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spreading depolarization-modulating drugs and delayed cerebral ischemia after subarachnoid hemorrhage: A hypothesis-generating retrospective clinical study.
    Hamming AM; Mulder IA; Gathier CS; van den Bergh WM; Dankbaar JW; Hoff RG; Vandertop WP; Verbaan D; Ferrari MD; Rinkel GJE; Algra A; Wermer MJH
    J Neurol Sci; 2016 Jul; 366():224-228. PubMed ID: 27288811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo.
    Wurm G; Tomancok B; Nussbaumer K; Adelwöhrer C; Holl K
    Clin Neurol Neurosurg; 2004 Mar; 106(2):97-103. PubMed ID: 15003298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of aneurysmal subarachnoid hemorrhage--focus on treatment, anesthesia, cerebral vasospasm prophylaxis, and therapy.
    Lin BF; Kuo CY; Wu ZF
    Acta Anaesthesiol Taiwan; 2014 Jun; 52(2):77-84. PubMed ID: 25016512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial Nitric Oxide Synthase Polymorphism Is Associated with Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage.
    Hendrix P; Foreman PM; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Tubbs RS; Shoja MM; Pittet JF; Mathru M; Griessenauer CJ
    World Neurosurg; 2017 May; 101():514-519. PubMed ID: 28254540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Initial Vasopressors Used for Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage.
    Roy B; McCullough LD; Dhar R; Grady J; Wang YB; Brown RJ
    Cerebrovasc Dis; 2017; 43(5-6):266-271. PubMed ID: 28319954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose intravenous heparin infusion in patients with aneurysmal subarachnoid hemorrhage: a preliminary assessment.
    Simard JM; Aldrich EF; Schreibman D; James RF; Polifka A; Beaty N
    J Neurosurg; 2013 Dec; 119(6):1611-9. PubMed ID: 24032706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a role for heparin in the management of complications of subarachnoid hemorrhage?
    Chimowitz MI; Pessin MS
    Stroke; 1987; 18(6):1169-72. PubMed ID: 3318003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker Discovery in Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage.
    Przybycien-Szymanska MM; Ashley WW
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1453-64. PubMed ID: 25957908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aneurysmal subarachnoid hemorrhage lead to systemic upregulation of IL-23/IL-17 inflammatory axis.
    Chaudhry SR; Güresir E; Vatter H; Kinfe TM; Dietrich D; Lamprecht A; Muhammad S
    Cytokine; 2017 Sep; 97():96-103. PubMed ID: 28609751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications.
    Chaudhry SR; Stoffel-Wagner B; Kinfe TM; Güresir E; Vatter H; Dietrich D; Lamprecht A; Muhammad S
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.